Science & Technology Review
|
2022, 40(14): 6-23
• Special to S&T Review •
The policies and strategies of personalized medicine in main developed countries and the enlightenment to the development of medicines in China
Full
LU Cainv, GAO Liubin, PENG Bo, GAO Yuehong, MAO Yanyan
Affiliations
Information Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Published: 2022-07-28
doi: 10.3981/j.issn.1000-7857.2022.14.001
Outline
The personalized medicine is widely studied and applied in recent years, especially in main developed countries. This paper reviews the development strategies and measures of the personalized medicine in main developed countries, including launching initiatives or bills, providing financial support, establishing research and industry alliances, building infrastructures and offering related courses or training programs. Then, from the perspective of the goals, the investments, the key areas and promotion methods of the personalized medicine extracted from the plans and the projects of major developed countries, it is shown that in the development of the personalized medicine the method of“Top Down”is mostly adopted, and the knowledge system of the medical industry has to be rebuilt, to develop large-scale crowd queues, invest hundreds of millions in R&D, accomplish multi-sector cooperation, and develop infrastructures for the data. Finally, this paper briefly analyzes the political, economic, social and scientific situations in China, and gives a few suggestions for the development of the personalized medicine in China, including the continuous investment in the infrastructure development, the medical data sharing, improving the medical supervision mechanism and developing the ethical polices, building a talent team and focusing on the collaboration, setting pilots of genetic clinics and promoting the new type of diagnosis and treatment step by step.
personalized medicine
/
precision medicine
/
Healthy China
LU Cainv, GAO Liubin, PENG Bo, GAO Yuehong, MAO Yanyan.
The policies and strategies of personalized medicine in main developed countries and the enlightenment to the development of medicines in China[J].
Science & Technology Review,
2022
, 40
(14)
: 6
-23
.
DOI: 10.3981/j.issn.1000-7857.2022.14.001
Year 2022 volume 40 Issue 14
PDF
584
102
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2022.14.001
- Receive Date:2021-12-10
- Online Date:2022-09-02
- Published:2022-07-28